Application Information

This drug has been submitted to the FDA under the reference 021437/001.

Names and composition

"INSPRA" is the commercial name of a drug composed of EPLERENONE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021437/001 INSPRA EPLERENONE TABLET/ORAL 25MG
021437/002 INSPRA EPLERENONE TABLET/ORAL 50MG
021437/003 INSPRA EPLERENONE TABLET/ORAL 100MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021437/001 INSPRA EPLERENONE TABLET/ORAL 25MG
021437/002 INSPRA EPLERENONE TABLET/ORAL 50MG
021437/003 INSPRA EPLERENONE TABLET/ORAL 100MG
078482/001 EPLERENONE EPLERENONE TABLET/ORAL 25MG
078482/002 EPLERENONE EPLERENONE TABLET/ORAL 50MG
078510/001 EPLERENONE EPLERENONE TABLET/ORAL 25MG
078510/002 EPLERENONE EPLERENONE TABLET/ORAL 50MG
203896/001 EPLERENONE EPLERENONE TABLET/ORAL 25MG
203896/002 EPLERENONE EPLERENONE TABLET/ORAL 50MG
206922/001 EPLERENONE EPLERENONE TABLET/ORAL 25MG
206922/002 EPLERENONE EPLERENONE TABLET/ORAL 50MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved